For torsades de pointes (polymorphic VT) in a stable pediatric patient, what is the recommended treatment and dose?

For torsades de pointes (polymorphic VT) in a stable pediatric patient, what is the recommended treatment and dose?

• A. Synchronized cardioversion
• B. Adenosine 0.1 mg/kg; then 0.2 mg/kg
• C. Amiodarone 5 mg/kg
• D. Magnesium sulfate 25 mg/kg IV/IO in 50 mL NS over 10 min

Answer: (D)

Torsades de pointes is a form of polymorphic ventricular tachycardia caused by abnormal repolarization, often linked to low magnesium and other electrolyte disturbances. In pediatric patients who are stable, magnesium sulfate is the treatment of choice because it helps stabilize cardiac membranes and suppress the early afterdepolarizations that sustain torsades, helping to terminate or prevent recurrence. The recommended dose is 25 mg/kg given IV or IO, diluted in 50 mL of normal saline and infused over about 10 minutes. If the rhythm recurs or persists, the dose can be repeated as needed while monitoring for possible hypotension. In many protocols, the max per-dose is considered up to certain limits (often up to 2 g in a single event), but follow your local protocol. Why this approach fits best: adenosine is for reentrant SVT and won’t treat torsades; synchronized cardioversion is reserved for unstable patients; amiodarone can be used for certain ventricular arrhythmias but does not address the magnesium deficiency driving torsades and may not be as effective here. Addressing electrolytes and the underlying cause is also important as part of overall management.

Torsades de pointes is a form of polymorphic ventricular tachycardia caused by abnormal repolarization, often linked to low magnesium and other electrolyte disturbances. In pediatric patients who are stable, magnesium sulfate is the treatment of choice because it helps stabilize cardiac membranes and suppress the early afterdepolarizations that sustain torsades, helping to terminate or prevent recurrence.

The recommended dose is 25 mg/kg given IV or IO, diluted in 50 mL of normal saline and infused over about 10 minutes. If the rhythm recurs or persists, the dose can be repeated as needed while monitoring for possible hypotension. In many protocols, the max per-dose is considered up to certain limits (often up to 2 g in a single event), but follow your local protocol.

Why this approach fits best: adenosine is for reentrant SVT and won’t treat torsades; synchronized cardioversion is reserved for unstable patients; amiodarone can be used for certain ventricular arrhythmias but does not address the magnesium deficiency driving torsades and may not be as effective here. Addressing electrolytes and the underlying cause is also important as part of overall management.